U.S. Rep. Jim Sensenbrenner
Press Release

Congressman Sensenbrenner Introduces the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017

Functional gastrointestinal and motility disorders affect two in five Americans.

By - Feb 16th, 2017 09:37 am

WASHINGTON, D.C. – Today, Congressman Jim Sensenbrenner introduced the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017 in the House of Representatives, which requests that the National Institute of Health (NIH) allocate time and already available resources to the research of functional gastrointestinal and motility disorders.

Functional gastrointestinal and motility disorders affect two in five Americans, causing great personal hardship on affected individuals and costing society more than $30 billion annually.

There are currently no known cures for these disorders, and lack of adequate research provides few treatment options. Further, these disorders are often misdiagnosed and improperly treated, resulting in increased patient suffering and additional financial burdens placed on patients and American taxpayers.

The Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017 requests that NIH dedicate time and already available resources to the research of functional gastrointestinal and motility disorders in the hope that such research would better equip medical professionals to accurately diagnose and treat these disorders, as well as potentially find lasting cures.

Additionally, this legislation will direct the National Institute of Diabetes and Digestive and Kidney diseases to provide continued funding for the advancement of gastrointestinal and motility research.

Congressman Sensenbrenner: “America is the world leader in medical research and technological advances. With time and resources dedicated to finding cures, I’m confident that we can help every American suffering with gastrointestinal and motility disorders and drastically improve their quality of life. This fiscally responsible, bipartisan bill received great support during the 114th Congress, and I look forward to working with my colleagues again this session to see it to the finish line.”

Mentioned in This Press Release

Recent Press Releases by U.S. Rep. Jim Sensenbrenner

Sensenbrenner Statement on Impeachment Resolution

"An unfair process can only lead to an unfair result, and this entire process has been fundamentally unfair to the President."

Sensenbrenner Will Retire at the End of the 116th Congress

"I think I am leaving this district, our Republican Party, and most important, our country, in a better place than when I began my service."

Rep. Sensenbrenner Statement on the Resignation of Rep. Sean Duffy

"Sean and Rachel Duffy are dear friends and proud patriots."

One thought on “Congressman Sensenbrenner Introduces the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017”

  1. EarlyWIsettlers_neverREPUBagain says:

    “No known cures.” That is simply untrue, and shows how uneducated and out-of-touch Sensenbrenner is. Calling for more research into what has already been researched; How pathetic! It’s been done; look it up. I bet he doesn’t even know where to look for that data. His interests are more into gerrymandering.

Leave a Reply

You must be an Urban Milwaukee member to leave a comment. Membership, which includes a host of perks, including an ad-free website, tickets to marquee events like Summerfest, the Wisconsin State Fair and the Florentine Opera, a better photo browser and access to members-only, behind-the-scenes tours, starts at $9/month. Learn more.

Join now and cancel anytime.

If you are an existing member, sign-in to leave a comment.

Have questions? Need to report an error? Contact Us